We are pleased to highlight the upcoming 21st Biennial ESID Meeting, set to take place from 16-19 October 2024 in Marseille, France. The meeting, themed “Human Inborn Errors of Immunity: An Expanding Universe,” is shaping up to be an essential event for the primary immunodeficiency (PID) community.

The local and international scientific committees are working to create an exceptional programme that covers the latest and most exciting discoveries in both basic and clinical science. Attendees will have the opportunity to explore the most recent developments in the diagnosis, management, and treatment of inborn errors of immunity (IEI). This includes insights into genetics and immunobiology, presented by internationally renowned scientists and clinicians through a variety of engaging formats such as keynote lectures, symposia, poster presentations, and interactive sessions.

The first day of the event will be dedicated to a highly regarded educational programme, offering outstanding lectures and interactive sessions designed to benefit students, trainees, and seasoned professionals alike. This programme will provide valuable updates on the pathogenesis, recognition, and management of IEIs, ensuring that all attendees receive practical and relevant insights into these complex conditions.

In addition to its educational sessions, ESID 2024 will include workshops and meet-the-expert sessions, creating opportunities for deeper engagement and collaboration among participants. Whether you’re presenting your research, networking with colleagues from around the globe, or sharpening your clinical skills, the meeting offers something for everyone involved in the field of immunodeficiencies.

This is an event not to be missed for those committed to advancing their knowledge and contributing to the future of primary immunodeficiency research and clinical care.

Important date: Register by 18 September to take advantage of early savings!

ESID 2024